Nebulised heparin for patients on ventilation: implications for COVID-19 pneumonia

Lorenzo BallMarcus J. SchultzPaolo PelosiIRCCS San Martino Polyclinic HospitalUniversità degli Studi di GenovaMahidol UniversityNuffield Department of MedicineAmsterdam UMC - University of Amsterdam2022-08-042022-08-042021-04-01The Lancet Respiratory Medicine. Vol.9, No.4 (2021), 321-32222132619221326002-s2.0-85100690597https://repository.li.mahidol.ac.th/handle/20.500.14594/78323Mahidol UniversityMedicineNebulised heparin for patients on ventilation: implications for COVID-19 pneumoniaNoteSCOPUS10.1016/S2213-2600(20)30513-0